Vitamin D Intake and Survival and Recurrence in Head and Neck Cancer Patients

By Eva B Yokosawa, A. Arthur, Katie M. Rentschler, G. Wolf, L. Rozek, A. Mondul. 2018

Subfields: Oncology, Otorhinolaryngology

Citations in the corpus

• Vitamin D and Clinical Outcomes in Head and Neck Cancer: A Systematic Review (2025, unknown): “However, our mixed survival outcomes—i.e., benefits in some studies (e.g., HR 0.73–0.84) [28,34,36] and none in others [26,35]—mirror the work of Wactawski-Wende et al. (2006), where 1000 IU/day provided no survival advantage across cancers (HR 0.98, 95% CI 0.91–1.05) [49].”